🇺🇸 FDA
Pipeline program

MaZiRenWan (MZRW)

PID-002

Phase 2 small_molecule completed

Quick answer

MaZiRenWan (MZRW) for Functional Gastrointestinal Disorders is a Phase 2 program (small_molecule) at Hong Kong Baptist University with 1 ClinicalTrials.gov record(s).

Program details

Company
Hong Kong Baptist University
Indication
Functional Gastrointestinal Disorders
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials